As shown in Figure 3A, we found that NF-кB inhibition significantly attenuated p65 and p-p65 levels and NF-кB-responsive and metastasis-associated proteins in DPP-4i-treated BC cells (Figures 3B, C). Here, LYPD5 is linked to breast cancer.